Schonfeld Strategic Advisors’s TG Therapeutics TGTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-21,390	Closed	-$638K	–	2676
2025 Q4	$638K	Buy	21,390 +3,986	+23%	+$130K	﹤0.01%	1299
2025 Q3	$629K	Buy	+17,404	New	+$573K	﹤0.01%	1584
2025 Q2	–	Sell	-27,735	Closed	-$1.09M	–	2546
2025 Q1	$1.09M	Buy	+27,735	New	+$933K	0.01%	1247
2024 Q4	–	Sell	-198,613	Closed	-$4.65M	–	2381
2024 Q3	$4.65M	Sell	198,613 -71,671	-27%	-$1.57M	0.04%	569
2024 Q2	$4.81M	Sell	270,284 -220,814	-45%	-$3.52M	0.04%	564
2024 Q1	$7.47M	Buy	491,098 +153,949	+46%	+$2.45M	0.06%	481
2023 Q4	$5.76M	Sell	337,149 -1,030,251	-75%	-$12M	0.05%	490
2023 Q3	$11.4M	Buy	1,367,400 +850,507	+165%	+$11.9M	0.11%	312
2023 Q2	$12.8M	Sell	516,893 -548,320	-51%	-$14.2M	0.11%	287
2023 Q1	$16M	Buy	1,065,213 +1,002,213	+1,591%	+$15.2M	0.15%	189
2022 Q4	$745K	Buy	63,000 +23,652	+60%	+$172K	0.01%	1314
2022 Q3	$233K	Sell	39,348 -396,983	-91%	-$2.6M	﹤0.01%	2254
2022 Q2	$1.85M	Buy	+436,331	New	+$2.72M	0.02%	769
2021 Q1	–	Sell	-23,537	Closed	-$1.22M	–	2127
2020 Q4	$1.22M	Buy	+23,537	New	+$795K	0.02%	744
2020 Q3	–	Sell	-44,479	Closed	-$867K	–	1661
2020 Q2	$867K	Buy	44,479 +23,261	+110%	+$375K	0.02%	643
2020 Q1	$209K	Buy	+21,218	New	+$268K	0.01%	901
2018 Q2	–	Sell	-33,277	Closed	-$472K	–	969
2018 Q1	$472K	Buy	+33,277	New	+$425K	0.04%	493